Cryoprecipitated Antihemophilic Factor from Human Plasma from United States
Cryoprecipitated Antihemophilic Factor from Human Plasma is a human plasma fraction rich in factor VIII, fibrinogen, and von Willebrand factor. It is prepared by thawing frozen plasma at 1-6°C and used to treat hemophilia A and fibrinogen deficiencies. This product falls under tariff item 3002.12.00 as a blood fraction for therapeutic use.
Duty Rate — United States → Canada
0%
Import Tips
• Obtain a Health Canada import permit for the cryoprecipitate as a biological product
• Provide documentation of the plasma source and preparation method to CBSA
• Declare under tariff item 3002.12.00 as a blood fraction for therapeutic use